Galmed Pharmaceuticals所有资讯

Galmed Pharmaceuticals | 20-F：年度报告/过渡报告/注册声明

04/05 04:57

Galmed Pharmaceuticals | 6-K：外国发行人报告

03/20 04:34

Galmed Pharmaceuticals | 6-K：外国发行人报告

03/15 21:15

Galmed Pharmaceuticals | SC 13G/A：超过5%持股股东披露文件(修正)-CVI Investments, Inc.(9.9%),Heights Capital Management, Inc.(9.9%)

02/15 03:18

Galmed Pharmaceuticals | SC 13G/A：超过5%持股股东披露文件(修正)-Biotechnology Value Fund, L.P.(0%),BVF I GP LLC(0%)等

02/14 22:57

Galmed Pharmaceuticals | SC 13G/A：超过5%持股股东披露文件(修正)-Allen Baharaff(6.2%),G. Yarom Medical Research Ltd.(4.5%)

02/13 05:22

Galmed Pharmaceuticals | EFFECT：其他

2023/11/30 13:15

Galmed Pharmaceuticals | POS AM：修改注册声明表

2023/11/23 05:48

Galmed Pharmaceuticals | 6-K：外国发行人报告（业绩相关）

2023/11/23 05:05

Galmed Pharmaceuticals | 6-K：外国发行人报告

2023/11/21 05:37

Galmed Pharmaceuticals | POS AM：修改注册声明表

2023/11/02 04:15

Galmed Pharmaceuticals | 6-K：外国发行人报告

2023/09/26 20:51

Galmed Pharmaceuticals | 6-K：外国发行人报告

2023/09/23 04:15

Galmed Pharmaceuticals | 6-K/A：外国发行人报告(修正)

2023/09/21 19:30

Galmed Pharmaceuticals | 6-K：外国发行人报告

2023/09/21 04:30

Galmed Pharmaceuticals | 6-K：外国发行人报告

2023/09/14 04:01

Galmed Pharmaceuticals | 6-K：外国发行人报告（业绩相关）

2023/08/10 04:43

Galmed Pharmaceuticals | 6-K：外国发行人报告

2023/08/10 04:30

Galmed Pharmaceuticals | 6-K：外国发行人报告（业绩相关）

2023/08/03 04:30

Galmed Pharmaceuticals | SC 13G：超过5%持股股东披露文件-CVI Investments, Inc.(9.9%),Heights Capital Management, Inc.(9.9%)

2023/07/21 22:12